{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:12:54Z","timestamp":1790921574418,"version":"4.1.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The ridaforolimus-eluting stent (RES) system is a novel cobalt alloy-based coronary stent with a durable elastomeric polymer eluting ridaforolimus. The aim of this trial was to assess the performance of a 38\u2005mm RES in long coronary lesions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A prospective, multicenter, single-arm, open-label clinical trial. Clinical follow-up was performed at 30\u2005days, 6\u2005months, and 1\u2005year after the procedure. Target lesions were located in native coronary arteries or bypass graft conduits, with visually estimated diameters of \u22652.75\u2005mm to \u22644.25\u2005mm. The primary endpoint was combined efficacy (final in-stent residual diameter stenosis &lt;30%) without 30-day major adverse cardiovascular events (MACE) (composite of cardiac death, any myocardial infarction), or ischemia-driven target lesion revascularization.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 50 patients were enrolled in the study. Fourteen (28%) had acute coronary syndromes; 17 (34%) had diabetes. The mean lesion length was 32.4\u2005mm\u2005\u00b1\u20058.3, reference vessel diameter 2.88\u2005mm\u2005\u00b1\u20050.45, minimal lumen diameter 0.80\u2005mm\u2005\u00b1\u20050.41, and percent diameter stenosis 72.6%\u2005\u00b1\u200513.2. The primary endpoint was achieved in 88% (44\/50) of the patients (95% confidence interval: 75.7\u201395.5%). Thirty-day and 1-year MACE rates were 6% and 8%, respectively. Target lesion failure after 1\u2005year occurred in three patients (6%). Forty-seven lesions (94%) were treated successfully, with final in-stent diameter stenosis of &lt; 30% [95% confidence interval: (84\u201399%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Percutaneous coronary intervention (PCI) of long lesions with a 38\u2005mm RES achieved satisfactory results, and support the safety and efficacy of PCI with RES in patients with long lesions. (ClinicalTrials.gov NCT03702608).<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mca.0000000000001264","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T14:06:17Z","timestamp":1689861977000},"page":"410-414","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Percutaneous coronary intervention with ridaforolimus-eluting stents in long lesions: the BIONICS 38\u2005mm prospective trial"],"prefix":"10.1097","volume":"34","author":[{"given":"Michael","family":"Jonas","sequence":"first","affiliation":[{"name":"Heart Institute, Kaplan Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ori","family":"Ben-Yehuda","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Foundation, Columbia University Medical Center, New-York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shmuel","family":"Banai","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Tel-Aviv Souraski Medical Center, Tel-Aviv University, Tel-Aviv"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Segev","sequence":"additional","affiliation":[{"name":"Cardiology Department, Sheba Medical Center, Tel-Aviv University, Ramat-Gan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haim","family":"Danenberg","sequence":"additional","affiliation":[{"name":"Cardiology Department, Wolfson Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abid","family":"Assali","sequence":"additional","affiliation":[{"name":"Cardiology Department, Meir Medical Center, Tel-Aviv University, Tel-Aviv"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ortal","family":"Tuvali","sequence":"additional","affiliation":[{"name":"Heart Institute, Kaplan Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Haberman","sequence":"additional","affiliation":[{"name":"Heart Institute, Kaplan Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Chernin","sequence":"additional","affiliation":[{"name":"Nephrology and Hypertension Institute, Kaplan Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,7,4]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0735-1097(99)00303-4","article-title":"Stented segment length as an independent predictor of restenosis.","volume":"34","author":"Kobayashi","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.amjcard.2003.12.018","article-title":"Very long sirolimus-eluting stent implantation for de novo coronary lesions.","volume":"93","author":"Degertekin","year":"2004","journal-title":"Am J Cardiol"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jacc.2009.11.052","article-title":"Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation.","volume":"55","author":"R\u00e4ber","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2217\/fca.13.50","article-title":"Very long stent technology: clinical and practical value.","volume":"9","author":"Menown","year":"2013","journal-title":"Future Cardiol"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"721","DOI":"10.4070\/kcj.2019.0150","article-title":"Diffuse long coronary artery disease is still an obstacle for percutaneous coronary intervention in the second-generation drug-eluting stent era?","volume":"49","author":"Oh","year":"2019","journal-title":"Korean Circ J"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/CIRCULATIONAHA.117.028885","article-title":"Randomized comparison of ridaforolimus- and zotarolimus-eluting coronary stents in patients with coronary artery disease: primary results from the BIONICS trial (BioNIR ridaforolimus-eluting coronary stent system in coronary stenosis).","volume":"136","author":"Kandzari","year":"2017","journal-title":"Circulation"},{"key":"R7-20250729","first-page":"e574","article-title":"2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines and the society for cardiovascular angiography and interventions.","volume":"124","author":"Levine","year":"2011","journal-title":"Circulation"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(08)61244-1","article-title":"Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial.","volume":"372","author":"Windecker","year":"2008","journal-title":"Lancet"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions.","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacc.2010.06.007","article-title":"Coronary stents.","volume":"56","author":"Garg","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1007\/s00330-012-2458-6","article-title":"Prevalence and prognosis of coronary stent gap detected by multi-detector CT: a follow-up study.","volume":"9","author":"Zhang","year":"2012","journal-title":"Eur Radiol"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4244\/EIJ-D-17-00890","article-title":"A prospective randomised trial comparing the novel ridaforolimus-eluting BioNIR stent to the zotarolimus-eluting Resolute stent: six-month angiographic and one-year clinical results of the NIREUS trial.","volume":"14","author":"Paradies","year":"2018","journal-title":"EuroIntervention"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4244\/EIJV5I1A24","article-title":"Coating irregularities of durable polymer-based drug-eluting stents as assessed by scanning electron microscopy.","volume":"5","author":"Basalus","year":"2009","journal-title":"EuroIntervention"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCINTERVENTIONS.110.959882","article-title":"Restenosis: delineating the numerous causes of drug-eluting stent restenosis.","volume":"4","author":"Farooq","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.amjcard.2013.06.012","article-title":"One-year outcomes of percutaneous coronary intervention with the 38-mm resolute zotarolimus-eluting stent.","volume":"112","author":"Lee","year":"2013","journal-title":"Am J Cardiol"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001264","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T18:02:34Z","timestamp":1753812154000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,4]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001264","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,4]]}}}